Measure Labs, Inc. (Dba Preemptiveai, Inc.)

Seattle, WA, United States All United States companies → — Founded 2022

Clinical AI Platform Developer Platform / API Healthcare Analytics / BI

Cardiology Family Medicine Internal Medicine

Cardiology AI Clinical Decision Support & Reference Developer Tools & APIs

Seed — $6.4M

Claim this company

Products

PreemptiveAI Clinical SDK

Measure Labs, Inc. (Dba Preemptiveai, Inc.)

Cardiology AI

A clinical software development kit using AI to model and predict cardiovascular health metrics, aiming to shift healthcare from reactive to proactive by providing early health risk signals.

See all 1 product →

About Measure Labs, Inc. (Dba Preemptiveai, Inc.)

Measure Labs, Inc., operating as PreemptiveAI, Inc., is a healthcare AI company focused on transforming healthcare from reactive disease management to proactive risk identification and prevention. The company has developed a “revolutionary” foundation model, a large-scale machine learning model, that interprets biomedical signals from smartphones and wearable devices to predict health outcomes in real-time. This technology aims to provide unprecedented insights into human physiology by leveraging advanced signal processing to analyze data such as photoplethysmography (PPG) signals.

For physicians, PreemptiveAI’s platform offers the potential for early disease detection, customized treatments, and proactive patient involvement. The AI model is designed to map human physiology and pathology in real-time, enabling providers to predict health outcomes like hospital readmissions and identify rising health risks. This approach not only facilitates early diagnosis and personalized care plans but also has implications for clinical care optimization, population health management, and accelerated drug development. PreemptiveAI emphasizes that its AI filters noise, allowing human clinicians to focus on meaningful signals, thereby enhancing patient care, improving outcomes, and driving significant cost savings.

Focus Areas

predictive health real-time health monitoring early disease detection AI in healthcare biomedical signal processing digital health population health management accelerated drug development

Business Intelligence

Key Investors	Inspired Capital, Meridian Street Capital, Precursor Ventures, MultiCare Capital Partners, AI2 Incubator, Paul Allen AI Institute, Hike Ventures, Evolution VC Partners, Good Friends
Partnerships	Duke University (Duke Health), Cove Communities, MultiCare Health System, Stanford Health Care, UW Medicine
Acquisitions	unknown
Technology	AI-driven biomedical foundation model, advanced signal processing, machine learning, cloud-native (implied by AI operating system approach)
FDA Clearances	1 cleared products (estimated)

What Physicians Need to Know

Predictive Health Monitoring

PreemptiveAI utilizes a large medical model to interpret biomedical signals from smartphones and wearable devices, creating a continuous data stream to predict health outcomes in real-time. This allows for early disease detection and personalized interventions before symptoms manifest.

AI in Healthcare & Biomedical Signal Processing

The company leverages advanced machine learning and deep learning technologies, including a foundation model trained on extensive datasets of human physiology and pathology. They specifically extend the capabilities of Photoplethysmography (PPG) signals to provide deep insights into the body's physiological state.

Digital Health & Population Health Management

PreemptiveAI offers a foundational layer beneath primary care, providing early signals to enable proactive care rather than reactive disease management. This approach aims to improve health outcomes, reduce costs, and optimize resource allocation for payors and healthcare providers.

Accelerated Drug Development

The predictive model can assist pharmaceutical companies with rapid design and customization capabilities, facilitating the development of tailored therapies.

Physician Tip

PreemptiveAI acts as a dedicated layer beneath primary care, providing early, human-guided insights from continuous physiological data. It does not replace your role but strengthens it by filtering noise and highlighting meaningful physiological shifts that require attention. The platform can help predict hospital readmissions, identify rising health risks, and inform personalized treatment plans, allowing for proactive interventions and more efficient resource utilization.

PreemptiveAI is designed for seamless integration with existing tools and workflows. Their agnostic architecture allows for leveraging a facility's existing technology stack, including wearables and EHR data feeds, to drive real-time clinical inferences. Data is designed to move seamlessly between EHRs and devices, ensuring alerts reach the right clinician at the right time.

At a glance

Founded 2022

HQ Seattle, WA, United States · United States

Team size 16

CEO Jamien McCullum

Funding Seed — $6.4M

FDA clearances 1 (estimated)

Products 1

Products by Measure Labs, Inc. (Dba Preemptiveai, Inc.)

1 product in the directory

PreemptiveAI Clinical SDK

Measure Labs, Inc. (Dba Preemptiveai, Inc.)

Cardiology AI

A clinical software development kit using AI to model and predict cardiovascular health metrics, aiming to shift healthcare from reactive to proactive by providing early health risk signals.

What the Web Says

Measure Labs, Inc., operating as Preemptiveai, Inc., appears to have a limited public review presence across major platforms like G2, Glassdoor, and Capterra. Information regarding specific product reviews or detailed employer experiences is scarce, making a comprehensive assessment challenging. The company's focus seems to be in the AI space, potentially within healthcare, given the 'Preemptiveai' name.

Overall: Mixed

Limitations

No significant limitations found in public reviews. Consider checking vendor documentation or requesting a demo for a thorough evaluation.

Based on reviews from: G2, Glassdoor, Capterra, Reddit, Healthcare IT Reviewers (general search)

Last updated: 2026-08-19

Videos

News, demos, and interviews about Measure Labs, Inc. (Dba Preemptiveai, Inc.).

Loading videos...

Videos load interactively. If none appear, search YouTube for Measure Labs, Inc. (Dba Preemptiveai, Inc.) →

View all on YouTube

Press & Coverage

Preemptive Health

Preemptive receives FDA 510(k) clearance

The U.S. Food and Drug Administration granted 510(k) clearance for the PreemptiveAI Clinical SDK (K250233), validating its core physiological modeling technology as a Class II medical device.

2026-02

Preemptive Health

Preemptive partners with Cove Communities to bring longitudinal care to residents

Preemptive is collaborating with Cove Communities to integrate proactive health monitoring directly into the residential experience for seniors in Central Florida.

2026-05

Preemptive Health

Preemptive Clinic, P.A. launches in Florida

Preemptive is establishing its first dedicated clinical practice in Florida, allowing members to access full longitudinal care directly through Preemptive.

2025-11

Preemptive Health

Duke Health and Preemptive validate early detection model for hospital readmissions

A retrospective study involving 200 patients showed Preemptive's physiological modeling identified risk signals 72 hours prior to readmission events with 84.7% AUC.

2025-01

Axios (reported on Preemptive Health)

Preemptive AI raises $6.4M for biomedical foundation model

Axios reported on Preemptive's seed funding round, led by existing investors, to build the first biomedical foundation model for predictive health.

2024-03

Preemptive Health

PreemptiveAI Emerges from Stealth

PreemptiveAI officially announced its launch and vision to shift healthcare from reactive to proactive using advanced physiological modeling.

2024-03

Preemptive Health

MultiCare joins Preemptive as strategic investor

MultiCare Health System joined Preemptive as a strategic investor through MultiCare Ventures, validating the need for a new physiological monitoring layer to support value-based care.

2023-09

Google Patents

Assessing patient health risks & predicting health events using biosignals from smartphones & other devices

Measure Labs, Inc. filed a patent application for systems and methods to assess patient health risks and predict health events using biosignals from smartphones and other devices.

2024-09

Frequently Asked Questions

What specific problems does Preemptiveai solve in predictive health and early disease detection for healthcare providers?

Preemptiveai leverages AI and biomedical signal processing to identify subtle patterns in patient data, aiming to predict health deteriorations and detect diseases earlier than traditional methods. This can lead to more timely interventions and improved patient outcomes by shifting from reactive to proactive care.

How does Preemptiveai's technology integrate with existing electronic health record (EHR) systems and real-time health monitoring devices?

Preemptiveai's solutions are designed for seamless integration with various EHR platforms and real-time monitoring devices, ensuring that data flows efficiently and securely. This allows healthcare providers to access predictive insights directly within their established workflows, minimizing disruption and maximizing utility.

What are the compliance and regulatory considerations for using Preemptiveai's AI in a clinical setting, particularly regarding patient data privacy (e.g., HIPAA)?

Preemptiveai prioritizes data security and privacy, adhering to stringent regulatory standards like HIPAA. Their platforms are built with robust security measures and compliance protocols to ensure the ethical and legal handling of sensitive patient information.

Can Preemptiveai's solutions be scaled for population health management, and what evidence supports their effectiveness in this area?

Preemptiveai's technology is scalable for population health management, enabling healthcare administrators to monitor and manage the health of large patient groups. While specific evidence would depend on individual case studies and deployments, the underlying AI models are designed to identify trends and risks across diverse populations.

What is the typical pricing structure for Preemptiveai's products, and what kind of ongoing support and training can our institution expect?

Preemptiveai offers flexible pricing models tailored to the specific needs and scale of healthcare institutions. They also provide comprehensive support, including initial implementation, ongoing technical assistance, and training for clinical and administrative staff to ensure effective utilization of their platforms.

How does Preemptiveai contribute to accelerated drug development, and what are the implications for pharmaceutical partnerships?

Preemptiveai's capabilities in analyzing biomedical signals and predicting disease progression can significantly accelerate drug development by identifying suitable patient cohorts for trials and evaluating treatment efficacy more precisely. This opens avenues for strategic partnerships with pharmaceutical companies seeking to optimize their R&D pipelines.

What is the long-term vision for Preemptiveai, and what is the company's stability and track record in the digital health market?

Preemptiveai aims to be a leader in AI-driven predictive health, continuously innovating to enhance early detection and personalized care. As 'Measure Labs, Inc. (Dba Preemptiveai, Inc.)', their stability is rooted in their commitment to advancing healthcare through technology and their ability to secure partnerships and funding.

Related Companies

Suggest an Edit →